IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION

Track this case

Case overview

Case Number:

2:16-md-02724

Court:

Pennsylvania Eastern

Nature of Suit:

Other Statutes: Anti-Trust

Multi Party Litigation:

Class Action, Multi-district Litigation

Judge:

CYNTHIA M. RUFE

Firms

Companies

Government Agencies

Sectors & Industries:

June 26, 2019
McKesson Dodges Generic Drug Price-Fix MDL For Now

A Pennsylvania federal judge nixed claims Wednesday that McKesson Corp. earned billions of dollars by cooperating with an industry-wide price-fixing conspiracy among generic-drug makers, ruling that a putative class' allegations in the multidistrict litigation are impermissible suppositions.
June 25, 2019
Big Pharma's Biggest New Cases Of 2019: Midyear Report

Multibillion-dollar lawsuits targeting major drugmakers emerged with astonishing frequency during the first half of 2019, threatening civil and criminal liability for all manner of alleged wheeling and dealing. Here, Law360 highlights the latest developments and upcoming action in the pharmaceutical world's hottest new cases.
June 24, 2019
Drugmakers' Emails, Calls Show Price-Fix Coverup, AGs Say

Unredacted emails and phone records show Teva Pharmaceuticals, Pfizer Inc. and 18 other major U.S. drug manufacturers conspiring in an industrywide price-fixing scheme to keep the cost of hundreds of generic drugs artificially high, according to a complaint unsealed Monday by the Maryland attorney general's office.
June 07, 2019
States Call For Unredacting Of Their Generic-Drug Pricing Suit

The attorneys general of 44 states and Puerto Rico want a Pennsylvania federal judge to make public an unredacted version of their suit accusing major drugmakers of orchestrating a sprawling scheme to fix the price of generics, saying the suit's subject matter was of "paramount public significance."
June 04, 2019
44 States' Generic-Drug Pricing Suit Rolled Into Pa. MDL

A lawsuit filed in Connecticut last month by 44 state attorneys general accusing drugmakers of a sprawling scheme to fix generic-drug prices was transferred Tuesday to the Pennsylvania federal court overseeing multidistrict litigation over pricing in the industry.
June 03, 2019
Drugmakers Want AGs' Generics Price-Fixing Claims Tossed

Pharmaceutical companies including Actavis, Teva and Mylan have asked a Pennsylvania federal court to dismiss state law claims by 47 state attorneys general against them in multidistrict litigation accusing them of price-fixing generic drugs.
May 16, 2019
United, Humana Say Classes Can't Carve Up Generic Awards

United Healthcare and Humana want the Pennsylvania federal court overseeing sprawling multidistrict litigation over generic drug prices to refuse to grant an order that would set aside part of any money the health care companies might win for the main class.
April 12, 2019
Judge Won't Certify Perrigo's Appeal In Drug Price-Fixing MDL

A Pennsylvania federal judge on Thursday refused to certify an interlocutory appeal from pharmaceutical company Perrigo on claims related to one drug in sprawling price-fixing multidistrict litigation, noting that even if the company's appeal goes through, it must still face claims related to other medications.
February 19, 2019
Generics Cos. To Face Most State Claims In Price-Fixing MDL

A Pennsylvania federal judge has largely refused to cull state law claims accusing numerous generic-drug makers of conspiring to fix prices, with only a handful of claims nixed from the massive multidistrict litigation on technical grounds.
February 01, 2019
AGs Want To Unlock Redacted Generic Price-Fixing Complaint

A group of state attorneys general and others accusing generic-drug makers of conspiring to fix prices for their products told a Pennsylvania federal judge on Friday that the public importance of the litigation warranted their previously redacted complaint being unsealed in full.

← Previous
…
5
6
7
8
9
10
11
12
13
Next →